Table 2

Results of the effect of age on post community-acquired pneumonia hospitalisation, in males and females

Age (years)Male OR (95% CI)*Female OR (95% CI)*
65–6911
70–741.35 (1.13 to 1.61)1.34 (1.10 to 1.61)
75–791.49 (1.26 to 1.76)1.39 (1.16 to 1.66)
80–841.65 (1.40 to 1.96)1.61 (1.35 to 1.93)
85–891.63 (1.36 to 1.94)1.47 (1.23 to 1.75)
≥901.59 (1.31 to 1.94)1.00 (0.84 to 1.19)
  • *Adjusted for: year, ischaemic heart disease, congestive heart failure, peripheral vascular disease, dementia, chronic lung disease, connective tissue disease, peptic ulcer, liver disease, diabetes, cancer, leukaemia/lymphoma, severe renal disease, cerebrovascular disease, neurological disease, disorders of the immune mechanism, terminal illness, recent carer, place of residence, vision problems, bed ulcer, underweight/nutritional replacement, incontinence/catheter, immunosuppressants (other than steroids), steroids, inhaled steroids, statins, antibiotics in previous 28 days, influenza vaccine.